Diverse and Active Roles for Adipocytes During Mammary Gland Growth and Function by Russell C. Hovey & Lucila Aimo
Diverse and Active Roles for Adipocytes During Mammary
Gland Growth and Function
Russell C. Hovey & Lucila Aimo
Received: 26 July 2010 /Accepted: 6 August 2010 /Published online: 19 August 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract The mammary gland is unique in its requirement
to develop in close association with a depot of adipose
tissue that is commonly referred to as the mammary fat pad.
As discussed throughout this issue, the mammary fat pad
represents a complex stromal microenvironment that
includes a variety of cell types. In this article we focus on
adipocytes as local regulators of epithelial cell growth and
their function during lactation. Several important consid-
erations arise from such a discussion. There is a clear and
close interrelationship between different stromal tissue
types within the mammary fat pad and its adipocytes.
Furthermore, these relationships are both stage- and
species-dependent, although many questions remain unan-
swered regarding their roles in these different states.
Several lines of evidence also suggest that adipocytes
within the mammary fat pad may function differently from
those in other fat depots. Finally, past and future technol-
ogies present a variety of opportunities to model these
complexities in order to more precisely delineate the many
potential functions of adipocytes within the mammary
glands. A thorough understanding of the role for this cell
type in the mammary glands could present numerous
opportunities to modify both breast cancer risk and
lactation performance.




IGF-I insulin-like growth factor-I
HGF hepatocyte growth factor
VEGF vascular endothelial growth factor
Introduction
Any discussion of processes involving mammary gland
growth, differentiation, lactation or involution is generally
centered about changes within the epithelial tissue [1–3].
However, a unique and fascinating aspect of mammary
gland biology is the requirement for mammary epithelial
cells to grow and function in a stromal environment
referred to as the mammary fat pad [4]. Crucial to this
environment are the resident adipocytes [5]. Whereas this
depot of adipose tissue was once viewed as a relatively-
inert matrix, it is now well-recognized that such a proposal
is far from true [4]. Beyond the growth- and function-
modulating properties of the adipocytes, this environment
ultimately dictates the extent to which the glandular
epithelium of an individual can develop into a functional
mammary gland [6], which may positively influence the
amount of mammary gland growth and milk yield [7].
However, there are also notable variations within the
mammary adipose tissue across species which can marked-
ly impact states such as breast cancer that warrant
recognition and discussion [5]. In this article we will
review past and current evidence revealing how adipocytes,
specifically within the mammary fat pad, can regulate
epithelial growth and function, with a specific focus on the
normal gland. We then summarize possible mechanisms by
which adipocytes might exert their effects. Finally, we
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make brief mention of experimental approaches that have
been used to dissect the roles of adipocytes in the mammary
glands.
Roles and Functions of Adipose Tissue
Adipose tissue plays critical roles during homeostasis
across all states in mammals, including during mammary
gland growth and lactation. However, in considering a role
for adipocytes in the mammary glands it is important to
appreciate the unique and diverse properties of these
fascinating cells. Several excellent articles provide an in-
depth review of this topic [8, 9]. White adipose tissue is
composed of adipocytes characterized as being unilocular,
where the cytoplasm of each cell contains a single, large,
cytoplasmic lipid droplet. By contrast, brown fat adipocytes
are multilocular and thereby contain several lipid droplets
with an interspersed cytoplasm. White adipose tissue is a
principal site for lipid storage whereas brown adipose tissue
serves a critical role during thermogenesis due to the
expression of uncoupling protein-1 and its sympathetic
innervation. These fat tissues also differ in their vascular-
ization, which is much more pronounced in brown fat.
While beyond the scope of this article, evidence also exists
to suggest that white and brown adipose tissue can undergo
transdifferentiation [10]. Along these lines, brown adipose
tissue is often found in distinct depots but can also be
interspersed among white adipose tissue [11].
Adipose Tissue in the Mammary Glands During
Development and Function
The Embryonic-neonatal Period
The mammary fat pad undergoes significant changes during
mammary gland growth and function. During embryogen-
esis the mammary anlage is intimately associated with a
mesenchyme that serves critical roles during induction of
the mammary epithelium [12]. At birth, the primitive
epithelial structures lie juxtaposed to a depot of adipose
tissue, although its presentation differs across species. In
rodents, adipocytes of the mammary fat pad differentiate
around days 16–17 of fetal life [13], thereby enabling the
ductal anlage to extend across its bounds and become
positioned in a sizeable, well-developed fat pad by the time
of birth [13]. In humans the ductal structures of neonates
are often embedded within a connective tissue stroma [14,
15], but have also been found in close apposition with
nearby islands of variably-sized vascularized, differentiated
embryonic fat [14]. This embryonic fat tissue was charac-
terized as having vascularized preadipocytes surrounded by
collagen-IV, which is similar to that seen in the rodent
mammary gland [15]. In the embryonic heifer the mamma-
ry fat pad begins to develop around day 80 of a 9-month
gestation [16] to become well-established by birth. At this
stage there are notable connective tissue septa throughout
its volume [5, 17]. A similar situation exists in neonatal
ewe lambs [18, 19]. In these species the epithelial elements
are embedded within an intralobular stroma, separate from
the adipose tissue. A micrograph depicting a rudimentary
duct within the mammary gland of an immature postnatal
Beagle bitch similarly reveals its position within a
connective tissue stroma separate from adipocytes [20].
Likewise, our observations in pigs indicate that the
epithelial ducts within the late-gestation fetus lie within a
fibrous stroma at the edge of the clearly-demarcated
embryonic fat pad (Madrak and Hovey, unpublished).
Postnatal Development
As discussed earlier within this issue [21], the mammary fat
pad in the postnatal female is a collective term for the
stromal environment into which the parenchyma develops.
Many of its individual components are also discussed in
detail elsewhere in this issue. However, brief mention will
be made here about the relationship between these
components and the mammary adipose tissue in which
they develop and function. Bani-Sacchi and colleagues
characterized the evolution of mammary adipose tissue of
mice in detail, presenting the cytological progression of
adipocytes and their evolution from perivascular mesen-
chymal cells [22]. This progression involved initial matu-
ration of “pale” preadipocytes with well-developed
organelles and few, small lipid droplets into “dark preadi-
pocytes” that were undergoing active lipid accumulation.
These preadipocytes then progressed to globular, multi-
vacuolated adipocytes, and finally presented as mature,
unilocular white adipocytes [22].
Matsumoto and colleagues described the nature of
adipocytes and the vasculature in the inguinal mammary
glands of ovariectomized, hormone-treated mice [23, 24].
In ovariectomized females, and in those treated with
progesterone, they noted the presence of multilocular
adipocytes specifically in the vicinity of the inguinal lymph
node and the major blood vessels [23]. By contrast,
estrogenized females had adipocytes that were predomi-
nantly unilocular, as was also observed in ovary-intact
females [23]. Along these same lines, we have observed the
increased mass of the mammary fat pads of estrogenized
mice (unpublished observation). These data are consistent
with the demonstration that estrogen induced hyperplasia of
adipocytes within the mammary fat pad. This effect was
amplified by relaxin, whereas relaxin alone induced
adipocyte hypertrophy [22].
In order to study lactation-associated changes within the
mammary fat pad during lactation, Matsumoto and
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colleagues starved mice and then examined adipocytes in
the mammary glands in an attempt to mimic similar
homeorrhetic changes during lactation [25]. These authors
found that mammary adipocytes assumed a multilocular
appearance during starvation, often as clusters of cells,
resembling those present in the mammary glands during
lactation. Interestingly, they also observed concurrent lipid
droplet formation in the mammary epithelium, consistent
with the results from recent studies that ablated mammary
adipocytes [25].
Any discussion regarding the mammary adipose tissue
microenvironment in mice should mention the fact that
brown adipose tissue forms part of the thoracic mammary
gland fat pad complex [5, 26]. It is interesting that this
microenvironment apparently supports normal development
and function of the epithelium, consistent with the finding
of Hoshino who achieved a high recovery rate for
epithelium grafted to the interscapular depot of brown
adipose tissue [5]. More recent evidence indicates that
white and brown adipocytes may be able to transdifferen-
tiate between the two cell types [27], raising the possibility
that mammary epithelial cells (in mice at least) normally
grow amongst both types of adipocytes (Fig. 1). Along
these lines, a microarray approach identified a brown
adipose-specific gene signature in the mammary glands of
mice that was abundant in prepubertal females, and that
was cold-inducible [28]. It is possible, however, that these
findings reflect contamination of tissue samples by brown
adipocytes from the thoracic mammary glands. Regardless,
these combined data raise interesting questions about roles
for white versus brown adipocytes in the mammary gland
and their role(s) during growth and lactation.
The full process of vascular development within the
mammary glands of mice is outlined in detail by others
elsewhere in this issue [29]. Clearly, however, there is a
crucial relationship between development of the mammary
fat pad and the associated vasculature during postnatal
development [23, 24, 30]. Master et al. identified that
expression of several regulators of angiogenesis, including
VEGF ligand and its receptors, were abundant in the
mammary glands of mice at 2 weeks of age (which are
primarily adipose tissue at this stage) during the same
period that brown fat cell differentiation was being recorded
[28]. Consistent with these data, we previously showed that
adipocytes within the mammary fat pad developmentally
express several VEGF isoforms, where the Flk-1 receptor
was most abundant in the neonatal cleared fat pad [31].
Hence, it appears that early establishment of the vasculature
throughout the mammary fat pad may depend on crosstalk
with the adipocyte population and its development, consis-
tent with findings for other adipose depots [31]. The
coordinated, early development of the mammary adipose
tissue and its associated vasculature [32] and the parallel
expression of respective genetic markers during this
window [28] coincides with recent evidence showing that
adipocytes probably arise from a progenitor niche within
the adipose vasculature [33]. Relative to the normal
mammary gland, the surgically-cleared mammary fat pad
maintains a normal vascular supply, although further
angiogenesis and its hormonal induction required the
presence of the interspersed mammary epithelium [30].
The Pregnancy-Lactation-Involution Transitions
The activity of mammary adipocytes is perhaps most
obvious during the transitions from pregnancy to lactation,
and into involution. Adipocytes within the mammary
glands of rats increased their cross-sectional area by
approximately 20% as they transitioned between the non-
pregnant state and day 11 of gestation, and then maintained
similar dimensions until day 20 of gestation [34]. These
same observations were made by Elias et al. who
emphasized that enlargement of the mammary glands
during pregnancy is not accompanied by adipocyte deple-
tion but rather parenchymal expansion [35]. Adipocytes
within the mammary glands displayed an increased inci-
dence of cell surface-associated vesicles during pregnancy
that ultimately were most abundant during lactation [35].
Adipocyte function within the mammary fat pad during
pregnancy is also both site-specific and epithelium-
dependent. Whereas abdominal fat pads from mice had
doubled their lipogenic rate (as measured by conversion of
14C-glucose to lipid) with the progression to pregnancy,
lipogenesis within the cleared mammary fat pad remained
static [36]. By contrast, adipocytes isolated from the intact
mammary glands of pregnant females also doubled their
lipogenic capacity compared to those in nulliparous females
[36]. These data are consistent with those of Bandyopad-
hyay et al. [37] who found that the lipid content of cleared
mammary fat pads remained constant during pregnancy,
which was in marked contrast to the pronounced lipogen-
esis within abdominal fat.
While data is lacking for changes within the mammary
adipose tissue in humans during pregnancy, there are
notable differences between adipose tissue in the breast
and other sites. Mammary adipocytes from postmenopausal
women undergo less norepinephrine-stimulated lipolysis
compared to those from premenopausal women, whereas
femoral adipocytes maintained a constant response [38].
Furthermore, the relative proportion of fibroblasts to
adipocytes in breast adipose tissue was similar to that for
abdominal adipose tissue, where the incidence of both cell
types was greater in breast adipose than in adipose from the
hip [39]. Along these same lines, adipose tissue from the
periphery of mammary glands in pregnant pigs was more
metabolically active than peritoneal fat and displayed the
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greatest level of lipid mobilization between days 75 and 90
of gestation, coincident with rapid mammary growth [39].
Mammary adipose tissue undergoes significant changes
during lactation that ultimately occur in support of milk
production. Many of these findings related to the transition
from pregnancy to lactation were made decades ago either
through ultrastructural analysis [35] or via enzymatic assays
[40, 41]. Shortly after parturition adipocytes within the
mammary glands of mice start to become depleted so that
they present as variably-sized multilocular fat cells along
with smaller unilocular adipocytes [35]. There are also
striking site-specific differences in the metabolism of
adipose tissues during lactation. Consistent with our own
unpublished observations, the cleared mammary fat pad
was consistently more resistant to lactation-induced lipol-
ysis compared to adipose depots such as the parametrial fat
pad [35, 36]. This site-specificity is fascinating and raises
questions as to whether white adipose tissue in the
mammary gland is conditioned to be more responsive to
local, epithelium-derived cues such as epithelium-secreted
lipoprotein lipase. Indeed, adipocytes in close proximity to
epithelial cells undergo more rapid depletion of their lipid
stores than those in either the cleared fat pad or in distal
areas of the fat pad separate from the mammary parenchy-
ma [35, 42]. Hence, both local and systemic influences
dictate lactation-induced lipolysis by mammary gland
adipocytes during lactation.
Surprisingly, there is only a limited understanding and
appreciation for the distribution and abundance of adipose
tissue within the normal human breast [43] or its role and
function during lactation [44]. Analysis of mastectomy
specimens indicated that the fat volume within the breast
among individuals ranged from 7 to 56% [45], while others
provided a categorical classification that revealed similar
variation [46]. By analyzing the lipid content of mammo-
plasty specimens, Lejour found that the fat content of
breasts from individual women ranged from 2 to 78%, with
an average of 48% [43]. Hartmann and colleagues [44]
employed ultrasound to characterize the incidence and
distribution of adipose tissue within the breasts of lactating
women. While adipose distribution within the left and right
breasts was similar, there were pronounced differences
between women regarding the abundance of adipose tissue
in the breast, which ranged from 16–51%. Subcutaneous,
intraglandular and retromammary fat stores occupied, on
average, approximately 24, 7 and 7% of the lactating breast
volume, respectively [44]. These simple descriptive studies
not only emphasize how little is appreciated about the
abundance of adipose tissue within the human breast at any
stage, but also how inconsistent it is between individuals.
Furthermore, whereas some studies found positive associ-
ations between breast fat content, age and obesity [43],
others did not [45].
The mammary epithelium of rodents undergoes a well-
characterized post-lactational regression during involution
[2]. During this same period, adipocytes within the
mammary glands replenish their lipid stores, first appearing
as small unilocular cells approximately 48 h after weaning,
then as fully-replenished unilocular adipocytes approxi-
mately 4 days later [35]. This replenishment of lipid in
adipocytes within the involuting mammary glands appears
to involve a crucial requirement for remodeling of the local
extracellular matrix. When plasma kallikrein activity was
blocked in involuting mice, thereby blocking plasminogen
conversion to plasmin, adipocyte replenishment was also
impaired [47]. When stromelysin or matrix metalloprotei-
nase activity was blocked, mammary adipocytes were
hypertrophic [48]. While the findings from these studies
encapsulate multiple events, they certainly do highlight an
important role for tissue remodeling during involuted-
induced lipogenesis by mammary adipocytes.
There is a paucity of information regarding changes in
the properties of mammary adipocytes in humans following
lactation. However, in postmenopausal women the propor-
tion of adipose tissue within the breast increases with age
concomitant with a decrease in the parenchymal component
[49].
In ruminants such as dairy cows the situation is different.
The mammary epithelium occupies the former mammary
fat pad during lactation, but then after involution (during
the “dry” period) the epithelium only undergoes limited
regression [50]. At this stage the associated stroma only
consists of fibrous connective tissue [51]. While there are
changes in the fibrous connective tissue during the dry
period [52], any low incidence of adipose tissue in the
udder of dry cows has not been quantified and likely does
not change based on fat content of the udder [51]. From an
observational standpoint it is worth noting that the udder of
dry cows is sometimes anecdotally referred to as resem-
bling a “wrung-out dishrag”, reflecting a failure of the
mammary gland to resume appreciable lipid deposition
during this period.
Mammary Adipose Tissue as a Source of Paracrine
and Endocrine Molecules
Depots of adipose tissue like the mammary fat pad have
become recognized as a site for the synthesis of many
diverse molecules (reviewed in [53]). The complex local
environment of the mammary adipose tissue ultimately
constitutes a reservoir of interstitial fluids that include both
locally-secreted molecules and those assimilated from distal
sites. Using a proteomics approach, Celis et al. identified
over 350 proteins within mammary adipose tissue [54]. The
provision of molecules in the local environment of the
mammary adipose tissue also raises intriguing questions
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about how their presentation at the local level might be
distinct from, or could modify, endocrine provision of some
of these same factors. While a comprehensive review of
adipose-derived molecules is beyond the scope of this
review, several specific examples are worth mentioning
given their potentially-important roles in the mammary
gland.
For many years prolactin was considered to be exclusive
to the anterior pituitary, then was subsequently found to be
synthesized by cancerous breast epithelium [55]. Now it is
clear that adipose tissue from various sites, including the
mammary glands of rodents and humans, can synthesize
prolactin [56, 57]. What remains unclear is whether this
locally-derived prolactin targets prolactin receptors on
epithelial or, perhaps stromal, cells. Regarding this point,
all prolactin receptor isoforms are expressed within the
epithelium-free mammary fat pads of mice [58], and these
undergo notable stage-specific changes in their expression.
Specifically, the long form of the receptor maintains its
expression in the mammary fat pad across all ages, whereas
expression of the variant short forms declines at different
rates during early life. Further potential for prolactin to
impact adipocyte maturation specifically within the mam-
mary gland is suggested by the fact that prolactin modifies
the function of mammary stromal preadipocytes in vitro
[59]. This finding is in keeping with the fact that
preadipocytes from prolactin receptor knockout mice fail
to differentiate in culture [60], where these same mice also
have reduced adiposity in white fat depots [61]. Clearly,
much remains to be established regarding any role for
adipocyte-derived prolactin during prolactin-mediated
growth and lactation. Separately, it is noteworthy that
prolactin inhibits lipoprotein lipase activity in breast
adipose tissue [62], which may have implications for the
release of lipid from local adipose stores in the mammary
glands either during neonatal development or lactation.
Considerable attention has been directed toward the
ability of adipose tissue to synthesize estrogens through
the expression of cytochrome aromatase p450. Support for
the concept that adipose tissue is a site of estrogen
biosynthesis has come from studies of the breast
(reviewed in [63]). A recent, noteworthy analysis of
transcription from the aromatase-encoding gene Cyp19A1
and its regulation in mice generated intriguing results [64].
Whereas appreciable aromatase expression was detected in
gonadal and visceral fat depots, none was detected in the
mammary glands of nulliparous 6 month-old female mice
(that almost certainly contained both epithelial and stromal
elements). Given the ability of epithelial cells to modulate
stromal function, it is conceivable that the absence of
Cyp19A1 expression in mammary adipocytes could be
directed by the adjacent epithelium. Alternatively, as
highlighted elsewhere in this review, the adipose environ-
ment of the mammary fat pad may be distinct from other
fat depots. Using cultured adipose tissue from cows,
Feuerrman et al. identified that aromatase expression was
prolactin-inducible, raising further possibilities for a local
endocrine loop between local prolactin and estrogen
biosynthesis [65]. Such a finding may be in keeping with
the earlier demonstration that aromatase expression in the
goat mammary gland was low, but increased during late
gestation [66].
Adipocytes and the associated stromal cells within the
mammary fat pad also represent a candidate target site for
both endocrine-derived and local estrogens. Estrogen
receptors (ER) have been detected in adipocytes and
fibroblasts within the mammary fat pads of mice [67],
heifers [68] and humans [69]. However, the precise roles
for these receptors remain unclear, although studies using
gene-ablated mice indicate an essential role for these
stromal receptors during ductal growth in the mouse [70].
Further confusion regarding this matter arises when discus-
sing the ER–α and ER–β isoforms given that the
predominant stromal isoform in mice appears to be ER-β
[71] whereas both isoforms have been localized to the
stroma of the normal human breast [72]. Meanwhile, ER-β
was undetectable in the mammary gland stroma from
heifers [73].
Stroma-derived insulin-like growth factor-I (IGF-I) has
earned considerable attention as a potent paracrine effector
of mammary gland growth. Several excellent reviews are
available on this topic [74, 75]. Kleinberg and colleagues
have provided several lines of evidence demonstrating that
the mammary fat pad provides essential, locally-
synthesized IGF-I that promotes growth of the ductal
epithelium. Furthermore, Richert and Wood localized IGF-
I mRNA expression within stromal tissue of the mammary
fat pad, which clearly included adipocytes [76], consistent
with the expression of IGF-I by subscapular adipose tissue
in rats [77]. Along these lines, we established that IGF-I
mRNA expression was increased in the proximity of the
parenchymal tissue within the mammary glands of ewe
lambs [78], whereas this was not the case in heifers [73].
This difference may reflect differences in the age or
parenchymal composition of these species. One
potentially-important finding regarding local IGF-I expres-
sion concerns its expression in the mammary fat pad
compared to other adipose depots. Interestingly, in both
rats [77] and heifers [73] there was the general finding that
the inductive effects of estrogen on IGF-I expression
occurred moreso in the mammary fat pad than in other
adipose depots. These data further support the idea that
adipocytes within the mammary glands may have unique
properties compared to those at other sites.
Hepatocyte growth factor (HGF) was originally shown
to be synthesized by mammary fibroblasts, but is also
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expressed by both adipocytes [79] and adipose-derived
stem cells [80]. Mammary epithelial cells treated with HGF
display a pronounced tubulogenic response in three-
dimensional culture, where HGF mediates effects of
estrogen on the mammary stroma [81]. Transforming
growth factor-β similarly is expressed by components of
the mammary fat pad [82] to potentially influence normal
epithelial growth and morphogenesis [83].
There is now a widespread appreciation that adipose
tissue within the body is an active endocrine organ that
serves as the source for several metabolism-regulating
hormones that have been coined “adipokines” [53]. While
a full review of the functions and properties of all candidate
adipokines is not possible here, it is appropriate to at least
briefly mention observations related to the mammary fat
pad. Significant interest is being directed toward the role for
these various adipokines in the relationship between obesity
and breast cancer risk [84].
Leptin is produced by adipocytes within the mammary
gland [85], where its expression is increased by diet-
induced obesity concomitant with reduced ductal develop-
ment [86]. Likewise, a deficiency in leptin signaling has
pronounced effects on the mammary fat pad and ductal
development through unknown systemic mechanisms [87].
Interestingly, estrogen tended to increase leptin receptor
expression in the mammary fat pad but not in other
subcutaneous adipose tissue depots in heifers [88]. Another
adipokine, adiponectin, is apparently indespensible for
mammary gland growth in mice [89]. However, transgenic
overexpression of adiponectin apparently suppresses ductal
development [89], although the promoter used in these
mice was not defined. Several other adipokines such as
tumor necrosis factor-α and interleukins have also been
implicated in the response of mammary adipocytes to
obesity [90] or the growth-modulating effects of dietary
conjugated linoleic acid [91].
Beyond this brief discussion of how certain adipokines
affect the mammary epithelium, it is important to note that
these same molecules have pronounced effects on other
components within the mammary fat pad including the
vasculature, the lymphatics, cells of the immune system,
and the connective tissue. Such an example is vascular
endothelial growth factor (VEGF) that is expressed by
adipocytes within the mammary fat pad in an isoform-
specific fashion during mammary development and lacta-
tion [31]. As a result, adipocytes within the mammary fat
pad may regulate angiogenesis and, in turn, subsequent
epithelial function during states such as lactation via their
production of molecules such as VEGF [31] and HGF [92].
While a full discussion of this cell-cell interdependency
within adipose tissue is not possible here, such a concept
has been reviewed elsewhere [53]. Regardless, it has
become clear, as raised elsewhere in this issue [21], that
adipose tissue within the mammary fat pad not only affects
the epithelium directly but also “cross-talks” with several
other stromal compartments to modulate their important
functions.
Adipose Tissue as a Source of Lipids and Their Metabolites
Adipocytes within the mammary glands are also highly
responsive to a female’s metabolic state. Of course, any
metabolic changes are also manifest throughout the body,
which hampers interpretations about specific roles for
adipocytes within the mammary glands during these states.
However, it is appropriate to at least briefly consider some
of these data. For example, dietary energy intake, fat
content and fat type have pronounced effects on mammary
development in rodents. Specifically, a deficiency in dietary
essential fatty acids impaired ductal and alveolar develop-
ment [93, 94]. Furthermore, increasing levels of dietary fat
increases mammary growth [95] that is generally associated
with adipocyte hypertrophy. Along these same lines a great
deal of effort is currently being directed toward under-
standing the relationships between obesity and breast
cancer risk in women that, at least in part, implicates roles
for adipocytes in the mammary gland microenvironment. In
a perhaps-similar situation, excess dietary energy intake
was historically implicated in the suppression of mammary
gland growth in heifers and lambs through increased
accretion of lipid in the mammary fat pad and associated
adipocyte hypetrophy [96]. However, this longstanding
phenotype was recently attributed to rapid sexual matura-
tion moreso than any direct effects of accelerated growth on
the mammary epithelium [97].
Adipose tissue within the mammary glands also likely
provides a local source of lipids and metabolites for the
mammary epithelium. Epithelial cells within the mouse
mammary gland are able to utilize fatty acids sequestered
from adipocytes of the mammary fat pad [37], where the
growth-promoting effect of medium conditioned by mam-
mary adipocytes can be simulated by exogenous unsaturat-
ed fatty acids [98]. These fatty acids can then be
metabolized to a variety of derivatives that have also been
shown to have both positive and negative effects on
epithelial cell growth and function [99]. In a recent study
we also identified that aberrant expression of an n-3
desaturase in the mammary epithelial cells of nulliparous
mice led to parallel, partial reproductive failure [100],
further supporting the notion that the mammary glands may
function as an endocrine organ [101].
Likewise, epithelial cells clearly induce lipolysis in
adjacent mammary adipocytes during lactation [35, 102],
presumably through the actions of epithelium-derived
lipoprotein lipase [102]. In turn, these adipocyte-derived
fatty acids can then be utilized for de novo fatty acid
284 J Mammary Gland Biol Neoplasia (2010) 15:279–290
synthesis by lactating mammary epithelial cells. In addition,
several groups have reported that exogenous unsaturated
fatty acids might influence lactogenesis. Whereas Nandi
and colleagues found that β-casein synthesis by primary
mammary epithelial cells was increased by linoleic acid in
culture [103], a recent report identified the opposite effect
in that both oleic and linoleic acids promoted the
degradation of hormone-induced β-casein [104]. This latter
finding may be explained by time-dependent changes in the
response of mammary epithelial cells to these fatty acids in
culture [105]. Regardless, these data highlight the potential
for local, adipocyte-derived fatty acids to modulate the
differentiated function of mammary epithelial cells, in
addition to their growth.
In Vivo and In Vitro Models to Study Roles for Adipose
Tissue in the Mammary Glands
Any discussion regarding the role of the mammary stroma
centers about elucidating the role for different cell pop-
ulations, including adipocytes, during mammary gland
growth and function. Of course this is not the simplest of
issues. However, various models have been utilized that are
worthy of discussion here, both for their utility and
contributions.
Various in vitro methods have been developed and
employed to assess the role for adipocytes in regulating
the normal growth and function of mammary epithelial
cells. Several groups have used approaches including
enzyme-dissociated adipocytes, preadipocytes, or explants
of mammary fat pad tissue [98, 106] to prepare conditioned
medium for addition onto mammary epithelial cells.
Separately, we have found utility in co-culturing mammary
fat pad in a floating system [107], whereas others co-cast
explants of mammary fat pad in collagen gels alongside
epithelial organoids [108]. More recently, others have
simulated both the physical (extracellular matrix) and
cellular (preadipocytes) components of the mammary
stromal environment using more elaborate culture models
[109].
Early in vivo transplantation approaches provided some
of the most convincing evidence that the mammary adipose
environment is critical for mammary gland growth and
development. Faulkin and DeOme’s “cleared fat pad”
surgical approach provided a model that has since become
widely adopted wherein epithelial cells (with diverse
backgrounds such as normal, precancerous, cancerous,
xenografted and genetically-modified) can be transplanted
into the adipose matrix of the mouse mammary fat pad
[110]. We have applied this same cleared fat pad approach
to other species including sheep [18] while others have
done the same in heifers [111]. The importance of the
adipose environment for the mouse mammary gland was
subsequently clarified using this approach. For example,
normal mouse mammary epithelial cells will develop upon
transplantation to any adipose tissue depot [6] including
brown adipose [112], although among the white adipose
tissue depots the cleared mammary fat pad tended to
support the most growth [6]. Likewise, transplantation of
mammary grafts to subcutaneous sites failed to demonstrate
any growth beyond the white adipose tissue [6, 113].
Further studies also raised the interesting question as to
whether the mammary fat pad is immunologically-
privileged compared to other adipose sites [113, 114], a
proposal that was later called into question using immuno-
genic tumor cell lines [114]. However, this topic may
warrant revisitation in light of the more-recent revelations
regarding the role of the immune system in mammary gland
growth. Interestingly, the location of the recipient fat pad
can also dictate metastatic growth, where metastases from
the mammary fat pad primarily arise in the lung whereas
those transplanted into ovarian or mesenteric adipose
tissues generally occur in the liver, spleen and diaphragm
[115]. However, mammary epithelial cells from different
species likely do not all have the same requirement for an
adipose tissue environment that is found in the mouse.
Similar to mouse mammary epithelial cells, normal epithe-
lial cells from rats, but not tumor cells, also can fully
repopulate the mammary fat pads of nude mice [116]. By
contrast, mammary epithelial cells from both humans and
cows fail to outgrow in this same adipose tissue environ-
ment, but instead form quiescent cysts [16]. As discussed
by Sheffield, this outcome may well reflect the greater
abundance of connective tissue stroma in these species [16].
That proposal has been validated through the recent
establishment of the human-in-mouse model, wherein
fibroblasts from human breast tissue facilitate the establish-
ment and morphogenesis of human mammary epithelium
[117]. Whether the same requirement for stromal supple-
mentation holds true for epithelium derived from species
including ruminants remains to be determined.
Genetically-manipulated animal models have also pro-
vided excellent opportunities to further probe specific roles
for the adipose tissue environment within the mammary
glands. One such approach was ablation of adipocytes by
overexpression of the A-ZIP/F transcription factor under
direction of the AP2 promoter [118]. From these mice it
was proposed that ductal elongation, but not alveolar
development and lactation, were adipocyte-dependent.
However, additional negative metabolic outcomes in these
mice potentially confound a full interpretation of their
mammary phenotype. To address these issues, Scherer and
colleagues recently generated FAT-ATTAC mice that
allowed for stage-specific ablation of adipocytes using
chemically-induced FKBP-caspase 8 dimerization [119]. It
is noteworthy that while dimerization-induced apoptosis
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should occur in all adipose tissues of these females, the
authors note that the mammary fat pad was more
susceptible to these changes than other depots. Like the
AP2-ZIP mice, these mice have a reduced incidence of
terminal end buds (up to 4.4 fold) and impaired ductal
elongation, although this difference (~3 mm at 6 wk of age)
was not as pronounced as might be expected after the
ablation of adipocytes. By contrast, adipocyte ablation in
sexually-mature females promoted precocious alveologen-
esis, epithelial differentiation and secretion.
Recombination of genetically-modified epithelial and
stromal tissues has also been a powerful tool for determin-
ing the function of the mammary fat pad and its
components. While the list of such transplant recombinants
has become extensive, it is worth noting that this approach
has led to important findings regarding the role of hormone
and growth factor receptors, extracellular matrix molecules,
soluble factors and non-adipocyte components within the
collective tissues of the mammary fat pad [70, 120]. The
ability of mammary epithelium to grow in adipose tissue
has enabled these transplants to be performed either in the
cleared mammary fat pad or as an epithelial-adipose
recombinant under the kidney capsule [70].
These complex approaches obviously limit their use to
study the role of the adipose microenvironment in humans.
However, one approach worth mentioning in the context of
adipose tissue function is breast fat grafting. This approach
has gained recent widespread adoption for treating women
in cases such as post-surgical disfigurement, genetic
abnormalities or for breast augmentation [121]. Interesting-
ly, grafted adipose tissue appears to be better-supported in
the subcutaneous and interglandular sites relative to the
retroperitoneal adipose depot [121, 122]. While this method
has attracted much discussion about its safety, it also has
the potential to incorporate much of our current under-
standing about adipocyte stem cell function to breast
biology [122]. Of course, the obvious major concern relates
to whether any modification of the mammary adipose
environment within the breast may influence a woman’s
breast cancer risk. Ultimately, such concerns will only be
addressed by better-resolving the function of the mammary
fat pad and its adipocytes in all species.
Conclusions
As outlined above, adipocytes within the mammary gland
are clearly dynamic and crucial for the growth and function
of the mammary epithelium. Yet, many questions remain
unanswered. For example, it remains unclear whether
adipocytes within the mammary glands are functionally
distinct from those in other depots. Adipocytes in the
mammary gland are also likely to modulate the function of
other extra-epithelial cell types, such as those discussed in
this issue. However, the full extent of these interrelation-
ships is only beginning to surface. Likewise, mammary
epithelial cells have an inherent requirement to reside
among adipocytes in vivo, at least in mice. Why? Finally,
Fig. 1 Diverse relationships be-
tween adipose tissue and the
mammary epithelium. a and b)
Photomicrographs of epithelial
ducts within the #3 thoracic
mammary glands from the same
pubescent female Balb/C mouse
at 55 d of age invested within a)
unilocular, white adipose tissue
and b) multilocular, brown adi-
pose tissue. Both adipose tissue
types are associated with the
thoracic mammary glands in
mice. Hematoxylin and eosin. c)
Epithelial ducts growing within
the mammary fat pad of a
nulliparous female pig, invested
within collagenous intralobular
stroma beyond which lies uni-
locular white adipose tissue. d)
Regressing alveoli within the
mammary gland of a post-
lactational sow showing inter-
spersed, lipid-filled adipocytes.
Magnification is same for all
panels, scale bar in panel A is
50 um
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a continually-emerging theme concerning any role for the
connective tissue stroma and its associated adipocytes
within the mammary glands are the striking differences in
this tissue compartment across species. This question
ultimately raises important issues about whether the
mammary fat pad in mice and the associated adipocytes
fully recapitulate this environment in humans or
economically-significant livestock species (Fig. 1).
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